Dr Reddy's Labs Q3 Results: Profit dips 14% YoY to ₹1210 crore; revenue grows 4%
The pharma major, part of the Nifty 50 index, said its net profit stood at ₹1209.8 crore in Q3 FY26 as against ₹1413.3 crore in the same period a year ago.
The pharma major, part of the Nifty 50 index, said its net profit stood at ₹1209.8 crore in Q3 FY26 as against ₹1413.3 crore in the same period a year ago.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
